Navigation Links
Vyopta Granted Cisco Preferred Solution Developer Partner Status, Highest Level for Cisco Developer Network
Date:3/11/2013

Austin, Texas (PRWEB) March 11, 2013

To take advantage of the benefits of the expanding role of the network, Vyopta Incorporated, the leading developer of business intelligence and process automation applications for video collaboration, today announced that it is now a Preferred Solution Developer within the TelePresence and Collaboration technology category of Cisco’s Developer Network Program.

Vyopta software applications (vAnalytics™, vAccess™, vPublish™, vSchedule™ and vControl®) fuse business video products into end-to-end solutions that transform the way companies utilize video. Vyopta solutions set the standard in quality, scalability and robust capabilities to support a variety of customer use cases, from automation and management of workflows for video collaboration, lecture capture and publishing, to powerful business analytics that transform the way companies measure the impact of video on their business.

The Cisco Developer Network unites Cisco with third-party developers of hardware and software to deliver tested interoperable solutions to joint customers, harnessing the power and intelligence of the network. As a Preferred Solution Developer, Vyopta has worked closely with Cisco to deliver enhanced solutions that deliver greater interoperability with Cisco networking solutions. Vyopta also shares Cisco’s strong commitment to customer service and satisfaction, has completed interoperability verification testing based on criteria set forth by Cisco, and can provide their customers comprehensive support. With Vyopta products, customers can more quickly deploy a broad range of Cisco Compatible business applications, devices, or services that can enhance the capabilities, performance, and management of the Cisco network. For more information on Vyopta interoperability with Cisco, visit http://www.vyopta.com.

“We are proud to have achieved Preferred Solution Developer Partner Status with Cisco,” said Alfredo Ramirez, President and CEO of Vyopta. “Teaming with Cisco further enables customers to benefit from interoperable solutions that transform how they collaborate, sell, educate, deliver patient care, and more.”

About Vyopta Incorporated
Vyopta is the leading developer of applications for video collaboration, enabling operations intelligence, customer service and content publishing automation that unleash the power of interactive video communications. Vyopta enables companies to do more with video – revolutionizing the way they sell, service, communicate and innovate. For more information on Vyopta, visit http://www.vyopta.com.

  • Interoperability testing is designed to simulate typical customer configurations, and does not replace the need for on-site testing in conjunction with actual implementation.

Vyopta and vControl are registered trademarks of Vyopta Incorporated, and the trademarks of the Vyopta family of products are trademarks of Vyopta Incorporated. All other trademarks referenced herein are the property of their respective owners.

Read the full story at http://www.prweb.com/releases/2013/VyoptaCDN/prweb10497051.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Tired Couples May Take Each Other For Granted
2. Trustifi Patent 8,341,023 Granted by USPTO and New Patent to be Issued for Postmarked Email
3. Professional Healthcare at Home Offering Geriatric Care Management Services in the San Francisco Bay Area
4. Fast Growing San Francisco Chiropractic Clinic Welcomes New Doctor, Dr. Anthony Gustin
5. Sean Sullivan San Francisco Real Estate New Construction: Discusses ”The Heights” In Pacific Heights, 14 New Luxury Condos
6. Damaka introduces Xabr™, a Native Mobile Video & Collaboration Client for Cisco® Jabber®, CallManager, and TelePresence
7. Paramount Lists Will Be Speaking At The National Postal Forum In San Francisco
8. Using an HRA to Comply with San Francisco's HCSO Requirements - Zane Benefits Publishes Information
9. American Society of Human Genetics to hold 2012 annual meeting, Nov. 6 to 10, in San Francisco
10. San Francisco is Hosting EB-5 Conference July 19, 2012
11. Special Needs Spotlight: Former SFMTA Board Member Bruce Oka Receives Treatment with San Francisco Sedation Dentist Dr. David Blende
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , ... March 27, 2017 , ... ... that for a second year in a row; they are the recipient of ... in the industry voted on the award at Design Connections 2017. Top A&D ...
(Date:3/27/2017)... California (PRWEB) , ... March 27, 2017 , ... The ... to its customers. First National Capital has added 10 new sales professionals over the ... its sales positions by 15 additional new hires over the course of 2017. ...
(Date:3/27/2017)... ... March 27, 2017 , ... Golden Triangle Emergency Center will ... April 3rd to commemorate the two-year anniversary of the facility. The event will ... two great years while also familiarizing themselves with the facility. , In the ...
(Date:3/26/2017)... ... March 26, 2017 , ... Local physician Dr. Justin Harper ... prestigious award honoring the top influencers on RealSelf—the most trusted online destination to ... and clinics. , In 2016, more than 82 million people visited RealSelf to ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... at the same time by providing Prehospital Trauma Life Support (PHTLS) course scholarships ... world’s premier prehospital trauma education developed in cooperation with the American College of ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... LightIntegra Technology Inc. today announced that its ... President and Chief Executive Officer effective March 13, 2017. ... Directors of LightIntegra. Paul Geyer will continue ... "This is the perfect time for Bill ... We,ve selected a very strong leader at a time ...
(Date:3/27/2017)... VANCOUVER, British Columbia, March 27, 2017  Sophiris ... "Company" or "Sophiris"), a clinical late-stage biopharmaceutical company ... with urological diseases, today reported fourth quarter and ... highlights. Key Corporate Highlights: ... for Localized Prostate Cancer. During 2016, the Company ...
(Date:3/27/2017)... , March 27, 2017   Pulmatrix, Inc . ... therapies to address serious pulmonary diseases, today announced that it ... disease, cystic fibrosis and asthma to its Scientific Advisory ... Richard B. Moss , MD, former chief ... of the Cystic Fibrosis Center at Stanford University, and ...
Breaking Medicine Technology: